Patents by Inventor PHILIP M. COCKS

PHILIP M. COCKS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tiotropium formulation and inhaler
    Patent number: 12220525
    Abstract: A metered dose inhaler equipped with a metering valve and having an aerosol canister containing a pharmaceutical composition comprising propellant, ethanol, citric acid, and tiotropium or a pharmaceutically acceptable salt or solvate thereof dissolved in the composition, wherein the aerosol canister has an internal surface that is a non-metal material that is in contact with the pharmaceutical composition.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: February 11, 2025
    Assignee: Kindeva Drug Deliver L.P.
    Inventors: Alexander D. Slowey, Philip M. Cocks, Neha A. Patel
  • INHALER
    Publication number: 20230081910
    Abstract: An inhaler comprising a valve having a valve volume of no more than 40 micro liters and a valve having a first layer comprising a silane and a second layer comprising a polyfluoropolyether silane—and albuterol.
    Type: Application
    Filed: February 24, 2021
    Publication date: March 16, 2023
    Applicant: KINDEVA DRUG DELIVERY L.P.
    Inventor: Philip M. Cocks
  • FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
    Publication number: 20210275439
    Abstract: A composition comprising particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof, particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof, and 1,1-difluoroethane.
    Type: Application
    Filed: June 5, 2019
    Publication date: September 9, 2021
    Inventors: Sarah J. Dexter, Philip M. Cocks
  • TIOTROPIUM FORMULATION AND INHALER
    Publication number: 20210260310
    Abstract: A metered dose inhaler equipped with a metering valve and having an aerosol canister containing a pharmaceutical composition comprising propellant, ethanol, citric acid, and tiotropium or a pharmaceutically acceptable salt or solvate thereof dissolved in the composition, wherein the aerosol canister has an internal surface that is a non-metal material that is in contact with the pharmaceutical composition.
    Type: Application
    Filed: June 26, 2019
    Publication date: August 26, 2021
    Applicant: KINDEVA DRUG DELIVERY L.P.
    Inventors: Alexander D. Slowey, Philip M. Cocks, Neha A. Patel
  • FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
    Publication number: 20210161804
    Abstract: A composition comprising particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof, particulate vilanterol trifenatate, at least one of 1,1,1,2,3,3,3-heptafluoropropane and 1,1,1,2-tetrafluoroethane.
    Type: Application
    Filed: May 31, 2019
    Publication date: June 3, 2021
    Inventors: Sarah E. Wrigglesworth, Philip M. Cocks, Alexander D. Slowey
  • FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
    Publication number: 20190054010
    Abstract: Compositions containing tiotropium or a pharmaceutically acceptable salt or solvate thereof, citric acid or a salt thereof, glycerol, ethanol, and a propellant, as well as aerosol canisters and inhalers containing the same. Methods of manufacturing and using the compositions, aerosol canisters, and inhalers.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 21, 2019
    Inventors: ALEXANDER D. SLOWEY, PHILIP M. COCKS, SARAH J. DEXTER